Molecular Partners Ag (MOLN) Operating Margin (2022 - 2025)
Molecular Partners Ag (MOLN) posted quarterly Operating Margin of 100000.0% for Q2 2025, up 102994513217.0% year-on-year from N/an in Q2 2024, and up 99.99% on a QoQ basis from 1030045132.17% in Q2 2024.
Molecular Partners Ag (MOLN) Operating Margin (2022 - 2025) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Operating Margin for 4 consecutive years, with 100000.0% the latest figure, recorded in Q2 2025.
- Quarterly Operating Margin rose 102994513217.0% year-over-year to 100000.0% in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 1.8% (changed N/A YoY) and the FY2025 annual result came in at 100041308.09%, down 10004008375.0% from the prior year.
- Operating Margin climbed to 100000.0% in Q2 2025 per MOLN's latest filing, from 1030045132.17% in the prior quarter.
- Over the last five years, Operating Margin for MOLN reached as high as 1297.44% in Q2 2022 and fell as low as 1030045132.17% in Q2 2024.
- A 4-year average of 257536915.49% and a median of 51913.61% in 2023 frame the typical range for Operating Margin.
- Annual changes were most pronounced in 2024 — Operating Margin sank 2000000000 bps — and 2025, when it soared 2000000000 bps.
- Year by year, Operating Margin stood at 1297.44% in 2022, then plunged by 395 bps to 3827.23% in 2023, then tumbled by 26913501 bps to 1030045132.17% in 2024, then jumped by 100 bps to 100000.0% in 2025.
- According to Business Quant data, Operating Margin over the past three periods registered 100000.0%, 1030045132.17%, and 3827.23% for Q2 2025, Q2 2024, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -100,000.00% |
| Jun 30, 2024 | -1,030,045,132.17% |
| Jun 30, 2023 | -3,827.23% |
| Jun 30, 2022 | 1,297.44% |